Medicared For All Logo

Daniel Geynisman in Philadelphia, Pennsylvania

Home Pennsylvania Philadelphia

Daniel Geynisman has Hematopoietic Cell Transplantation And Cellular Therapy as his primary medical specialty. Their primary office is: 7600 Central Ave in Philadelphia, Pennsylvania. There is an additional office location, for a total of two, for Daniel Geynisman that can be viewed further down.

They're a part of the: Temple Faculty Practice Plan Inc medical group which has around 1,070 members. You can call their office at 215-722-3258 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Pittsburgh School Of Medicine and graduated in 2006 (around 18 years of experience). They are listed as doing telehealth appointments.


Daniel M Geynisman Office Phone and Directions

Daniel Geynisman
Temple Faculty Practice Plan Inc
7600 Central Ave
Philadelphia, Pennsylvania 19111
215-722-3258


Patient Ratings
Please rate your experience with Daniel Geynisman below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 215-722-3258


Enter a starting address:


Healthcare Info for Daniel Geynisman

Additional Medical Specialties Include:
MEDICAL ONCOLOGY

Medical School: University Of Pittsburgh School Of Medicine
Graduation Year: 2006
The Primary Medical Specialty for Daniel Geynisman is listed as: Hematopoietic Cell Transplantation And Cellular Therapy
Approximate Years of Experience: 18
PAC (PECOS ID)#: 1850530056
NPI #: 1437343597
NPI Created On: 08/31/2007
NPI Last Updated Listed as: 04/09/2018
Primary Taxonomy Code: 207RX0202X
License Number:
MD436806
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Blue Cross Blue Shield
  • Highmark Health Insurance Company
  • Highmark Inc.
  • Geisinger Health Plan
  • Geisinger Quality Options
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. New patient office or other outpatient visit, typically 45 minutes
  2. Established patient office or other outpatient visit, typically 15 minutes
  3. Established patient office or other outpatient, visit typically 25 minutes
  4. Established patient office or other outpatient, visit typically 25 minutes
  5. Established patient office or other outpatient, visit typically 40 minutes
  6. Established patient office or other outpatient, visit typically 40 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $660

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788236239

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 799850551

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: ONCOLOGY

Name of Drug #1: FOUNDATIONONE

Drug or Biological: Device

Product Category #2: ONCOLOGY

Name Of Drug #2:: FOUNDATIONONE HEME

Drug or Biological #3:: Device

Product Category #3: ONCOLOGY

Name of Drug: FOUNDATIONONE CDX

Drug or Biological: Device

Product Category #4: ONCOLOGY

Name of Drug #4: FOUNDATIONFOCUS

Drug or Biological #4:: Device

Product Category #5: ONCOLOGY

Name of Drug #5: FOUNDATIONONE LIQUID CDX


Payments Total: $2,000

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 832187212

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01


Payments Total: $1,500

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783607829

Being Disputed:: No

Product Related: No


Payments Total: $28

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 836491491

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Prostate Cancer

Name of Drug #1: ELIGARD

Open Associated Drug #1: 62935-753-75


Payments Total: $1,500

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 832597275

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: INLYTA

Open Associated Drug #1: 0069-0145-01


Payments Total: $2,250

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 848494913

Being Disputed:: No

Product Related: No


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848531661

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: KEYTRUDA

Open Associated Drug #1: 0006-3029-02


Payments Total: $990

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Context of payment:: TPV TPV Non-Research Events and Meetings - Newer)-21621 RCC Virtual Steering Comittee Meeting Agg Spend Reportxlsx-3

Record ID:: 838865205

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CABOMETYX

Open Associated Drug #1: 42388-024-26


Payments Total: $990

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Context of payment:: TPV TPV Non-Research Events and Meetings - Newer)-42020 Virtual RCC Steering Comittee Agg Spend Reportxlsx-3

Record ID:: 838865287

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CABOMETYX

Open Associated Drug #1: 42388-024-26


Additional Office Locations

1. Temple Faculty Practice Plan Inc
3401 N Broad St
Philadelphia, PA 19140
Group Members: 1,070

Phone: 215-722-3258

Enter a starting address:


Hematopoietic Cell Transplantation And Cellular Therapy Professionals in Philadelphia

7600 Central Ave
Philadelphia, PA
Temple Faculty Practice Plan Inc

3401 N Broad St
Philadelphia, PA
Temple Faculty Practice Plan Inc

7600 Central Ave
Philadelphia, PA
Temple Faculty Practice Plan Inc

3401 N Broad St
Philadelphia, PA
Temple Faculty Practice Plan Inc

7600 Central Ave
Philadelphia, PA
Temple Faculty Practice Plan Inc

3401 N Broad St
Philadelphia, PA
Temple Faculty Practice Plan Inc

Providers in Temple Faculty Practice Plan Inc

1.Mackenzie Abate

3401 N Broad St
Philadelphia Pa 19140-5103
Temple Faculty Practice Plan Inc
Nurse Practitioner

2.Mackenzie Abate

3322 N Broad St
Philadelphia Pa 19140-5185
Temple Faculty Practice Plan Inc
Nurse Practitioner

3.Andrea Abbott

2301 E Allegheny Ave
Philadelphia Pa 19134-4427
Temple Faculty Practice Plan Inc
Diagnostic Radiology

4.Andrea Abbott

3401 N Broad St
Philadelphia Pa 19140-5103
Temple Faculty Practice Plan Inc
Diagnostic Radiology

5.Peter Abdelmessieh

7600 Central Ave
Philadelphia Pa 19111-2442
Temple Faculty Practice Plan Inc
Internal Medicine

6.Peter Abdelmessieh

3401 N Broad St
Philadelphia Pa 19140-5103
Temple Faculty Practice Plan Inc
Internal Medicine

View all 1,070 members of Temple Faculty Practice Plan Inc medical group